Michael Sela
29Patents
19h-index
31Co-inventors
81Inventor score
Filing activity: May 25, 1976 → Nov 10, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5800808A | Copolymer-1 improvements in compositions of copolymers | Chemistry; Metallurgy | 86 | Expired |
| US6054430A | Copolymer-1 improvements in compositions of copolymers | Chemistry; Metallurgy | 80 | Expired |
| US6048898A | Copolymer-1 improvements in compositions of copolymers | Chemistry; Metallurgy | 78 | Expired |
| US5981589A | Copolymer-1 improvements in compositions of copolymers | Chemistry; Metallurgy | 77 | Expired |
| US6342476B1 | Copolymer-1 improvements in compositions of copolymers | Chemistry; Metallurgy | 73 | Expired |
| US6362161B1 | Copolymer-1 improvements on compositions of copolymers | Chemistry; Metallurgy | 70 | Expired |
| US6620847B2 | Copolymer-1 improvements in compositions of copolymers | Chemistry; Metallurgy | 67 | Expired |
| US6214791A | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 | Human Necessities | 63 | Expired |
| US6939539B2 | Copolymer-1 improvements in compositions of copolymers | Chemistry; Metallurgy | 58 | Expired |
| US6844314B2 | Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy | Human Necessities | 57 | Expired |
| US7199098B2 | Copolymer-1 improvements in compositions of copolymers | Chemistry; Metallurgy | 56 | Expired |
| US7939072B2 | Anti-EGFR antibodies with an improved anti-tumor activity and compositions and articles of manufacture comprising same | Chemistry; Metallurgy | 33 | Active |
| US7279172B2 | Treatment of autoimmune conditions with copolymer 1 and related copolymers | Emerging Cross-Sectional Technologies | 33 | Expired |
| US4093607A | Immunologic chemotherapeutic agents comprising antigen binding dimers covalently bound to drugs | Emerging Cross-Sectional Technologies | 32 | Expired |
| US5858964A | Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of GVHD | Chemistry; Metallurgy | 30 | Expired |
| US7425332B2 | Treatment of autoimmune conditions with Copolymer 1 and related Copolymers | Emerging Cross-Sectional Technologies | 27 | Active |
| US7498142B2 | Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies | Chemistry; Metallurgy | 24 | Expired |
| US4263279A | Pharmaceutically active compositions containing adriamycin and daunomycin | Chemistry; Metallurgy | 22 | Expired |
| US7625861B2 | Copolymer-1 improvements in compositions of copolymers | Chemistry; Metallurgy | 21 | Active |
| US8367605B2 | Copolymer-1 improvements in compositions of copolymers | Chemistry; Metallurgy | 15 | Active |
| US7407936B2 | Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy | Human Necessities | 13 | Expired |
| US4075194A | Novel synthetic undecapeptide and clinical assay | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4401659A | Muramyl-peptides fixed to peptide-polymers and pharmaceutical compositions containing them | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6066621A | Synthetic peptides for the treatment of myasthenia gravis | Human Necessities | 5 | Expired |
| US4751064A | Synthetic chollera vaccine | Emerging Cross-Sectional Technologies | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.